Gemilukast
- Generic Name
- Gemilukast
A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma
- First Posted Date
- 2012-03-12
- Last Posted Date
- 2013-04-30
- Lead Sponsor
- Ono Pharma USA Inc
- Target Recruit Count
- 25
- Registration Number
- NCT01551147
- Locations
- ๐จ๐ฆ
Calgary Clinical Site 540, Alberta, Canada
๐จ๐ฆHamilton Clinical Site 550, Ontario, Canada
๐จ๐ฆSaskatoon Clinical Site 520, Saskatoon, Canada
A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients
- First Posted Date
- 2012-02-20
- Last Posted Date
- 2014-02-14
- Lead Sponsor
- Ono Pharma USA Inc
- Target Recruit Count
- 59
- Registration Number
- NCT01536041
- Locations
- ๐บ๐ธ
Raleigh Clinical Site 130, Raleigh, North Carolina, United States
๐บ๐ธDenver Clinical Site 160, Denver, Colorado, United States
๐บ๐ธSan Diego Clinical Site 140, San Diego, California, United States
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects
- First Posted Date
- 2011-07-29
- Last Posted Date
- 2012-06-14
- Lead Sponsor
- Ono Pharma USA Inc
- Target Recruit Count
- 24
- Registration Number
- NCT01405651
- Locations
- ๐บ๐ธ
Miramar Clinical Site, Miramar, Florida, United States
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects
- First Posted Date
- 2011-02-17
- Last Posted Date
- 2012-06-14
- Lead Sponsor
- Ono Pharma USA Inc
- Target Recruit Count
- 56
- Registration Number
- NCT01297582
- Locations
- ๐บ๐ธ
Miramar Clinical Site, Miramar, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2025. All Rights Reserved by MedPath